Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation

Recruiting now · Not applicable

Conditions studied: Liver Transplantation

In brief

Liver transplantation carries a substantial risk of bleeding, making precise haemostasis control essential, although assessing coagulation remains challenging. Quantra, a bedside viscoelastic testing device using sonorheometric methods, offers an innovative approach to guiding haemostatic management during surgery. The study aims to determine whether a Quantra-guided transfusion can reduce transfusion and bleeding during liver transplantation when compared to a conventional transfusion approach.

Key facts

Study ID

NCT06749405

Run by

University Hospital, Toulouse

People needed

56

Starts

2025-03-08

Expected to finish

2027-03-01

Last updated by the study team

2025-09-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 18 years or older
• Patient with ESLD undergoing liver transplantation
• Individuals affiliated with or beneficiaries of a social security scheme
• Free and informed written consent obtained in writing from the patient, or where applicable from the trusted person/family member/close relative
• Non-inclusion Criteria:
• Multi-organ transplantation
• Congenital haemostasis disorder (such as haemophilia)
• Patient under juridical protection (persons deprived of liberty or under curatorship or guardianship or safeguard of justice)
• Pregnant or breast-feeding woman
• Patient already enrolled in another interventional study with primary or secondary objective of reducing perioperative bleeding or transfusion

Where it is running

• Toulouse University Hospital — Toulouse, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.